Unmasking the Silent Epidemic: Testing for Nonalcoholic Fatty Liver Disease

Unmasking the Silent Epidemic: Testing for Nonalcoholic Fatty Liver Disease

Unmasking the Silent Epidemic: Testing for Nonalcoholic Fatty Liver Disease

Metabolic dysfunction-associated fatty liver disease, commonly referred to as MAFLD, previously known as Nonalcoholic fatty liver disease (NAFLD), is a silent epidemic silently gaining ground in our communities. 40% of adults in the US are unknowingly living with MAFLD, while most remain unaware. With obesity and metabolic syndrome on the rise, prevalence has skyrocketed making early diagnosis and intervention ever-more important than before.

In simple terms, MAFLD is the accumulation of fat in the liver cells, not due to alcohol consumption. It’s a condition that, when left unchecked, progresses to nonalcoholic steatohepatitis (NASH), leading to potentially fatal liver complications like cirrhosis. A significant number of people with MAFLD are predisposed due to metabolic dysfunctions such as insulin resistance, obesity, dyslipidemia, and hypertension.

Nonalcoholic fatty liver can lead to major health risks without clear symptoms. Request a FREE consultation for Fatty Liver Testing below. Call 706-739-7789.

Only five percent of those affected with MAFLD are aware they have it. Individuals at risk include overweight individuals with abnormal liver enzymes, those diagnosed with diabetes or prediabetes as well as individuals who possess cardiometabolic risk factors. Thanks to advances in medical technology, diagnosing MAFLD has become easier and more accurate than ever. Blood tests, imaging techniques, and advanced diagnostic techniques offer a complete picture of an individual’s liver health.

There is no specific medication that treats MAFLD. However lifestyle modifications, medical interventions, and regular monitoring can make a considerable difference – from adopting a balanced diet and regular exercise routines to managing associated conditions such as high blood pressure or diabetes – can make a difference and potentially reverse or manage MAFLD.

Are you in tune with your metabolic health? Given the escalating prevalence of MAFLD, early detection is the key. At RID-IC, our state-of-the-art MAFLD testing provides an in-depth evaluation of liver health and associated metabolic risks. With our dedicated team at your side providing insight and tools that can empower you to take control of your own wellbeing! Opt for our MAFLD screening today and steer your health toward a brighter future.

Leave a Reply

Your email address will not be published. Required fields are marked *